Volume 29, Number 10—October 2023
Research
Effects of COVID-19 on Maternal and Neonatal Outcomes and Access to Antenatal and Postnatal Care, Malawi
Table 3
Variable | Estimate (95% CI)† | p value |
---|---|---|
Baseline, intercept | 22.47 (22.14–27.04) | |
COVID-19 wave 2 | 1.04 (0.91–1.18) | 0.6225 |
COVID-19 wave 3 | 1.30 (1.14–1.47) | 0.0001 |
Time, wk | 1.00 (0.99–1.01) | 0.7905 |
Post COVID-19 wave 2 | 0.99 (0.98–1.00) | 0.1304 |
Post COVID-19 wave 3 | 1.00 (0.99–1.01) | 0.5393 |
*Pseudo R2 = 0.04. Bold text indicates statistical significance. †The estimates are exponentiated model coefficients, i.e., the intercept estimate is the baseline incidence rate per 1,000 live births and all other estimates are rate ratios associated with the different variables.
1These authors contributed equally to this article.
Page created: August 18, 2023
Page updated: September 20, 2023
Page reviewed: September 20, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.